Endothelium-derived relaxant factor inhibits platelet activation

Publisher Website
Google Scholar
Abstract
Summary Experiments were designed to investigate whether platelet activation is modulated by endothelium-derived relaxant factor (EDRF) which has been shown to induce vascular smooth muscle relaxation by direct stimulation of soluble guanylate cyclase. EDRF was released from cultured bovine endothelial cells, grown on microcarrier beads, by stimulation with thimerosal in the presence of indomethacin. EDRF had no effect on the intracellular free calcium concentration (Cai 2+, measured with the fluorescent indicator indo-1) of resting washed human platelets but significantly attenuated the thrombin-induced rise of Cai 2+ from 896 ± 99 (SEM) to 509 ± 48 nmol/l. EDRF significantly increased platelet cyclic GMP levels from 0.25 ± 0.04 to 2.5 ± 0.4 pmol/108 platelets and reduced the thrombin-induced aggregation to 23 ± 3% of control. EDRF had no effect on Caiz+, cyclic GMP or aggregation after a 3 min storage interval, but superoxide dismutase (shown to increase stability of the labile factor) significantly augmented the EDRF effects on Cai 2+. The antiaggregatory potency of EDRF was completely abolished in the presence of hemoglobin. The results characterize EDRF as a potent cyclic GMP-dependent antiaggregatory factor which may act synergistically in vivo with the cyclic AMP-dependent inhibitory effect of prostacyclin.

This publication has 26 references indexed in Scilit: